TAR DNA-binding protein 43 (TDP-43) is a 414 amino acid, predominantly nuclear ribonucleic acid (RNA)/deoxyribonucleic acid (DNA)-binding protein involved in RNA metabolism, messenger RNA (mRNA) transport, microRNA maturation, and stress granule formation.2 Cytoplasmic aggregation of TDP-43 can contribute to neurodegeneration through multiple loss- and gain-of-function mechanisms.1,2
In 2006, TDP-43 was identified as the major component of ubiquinated inclusions in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), providing compelling evidence of a shared molecular pathology between these disorders.3
TDP-43 pathology is observed at autopsy in approximately 97% of ALS cases and 45–50% of frontotemporal dementia (FTD) cases. It is also detected in a range of other neurodegenerative disorders, emphasizing the complexity of the molecular mechanisms underlying these conditions.1,2